Artificial Intelligence-Enhanced Quantitative Ultrasound for Breast Cancer: Pilot Study on Quantitative Parameters and Biopsy Outcomes.
Hyuksool KwonSeokhwan OhMyeong-Gee KimYoungmin KimGuil JungHyeon-Jik LeeSang-Yun KimHyeon-Min BaePublished in: Diagnostics (Basel, Switzerland) (2024)
Traditional B-mode ultrasound has difficulties distinguishing benign from malignant breast lesions. It appears that Quantitative Ultrasound (QUS) may offer advantages. We examined the QUS imaging system's potential, utilizing parameters like Attenuation Coefficient (AC), Speed of Sound (SoS), Effective Scatterer Diameter (ESD), and Effective Scatterer Concentration (ESC) to enhance diagnostic accuracy. B-mode images and radiofrequency signals were gathered from breast lesions. These parameters were processed and analyzed by a QUS system trained on a simulated acoustic dataset and equipped with an encoder-decoder structure. Fifty-seven patients were enrolled over six months. Biopsies served as the diagnostic ground truth. AC, SoS, and ESD showed significant differences between benign and malignant lesions ( p < 0.05), but ESC did not. A logistic regression model was developed, demonstrating an area under the receiver operating characteristic curve of 0.90 (95% CI: 0.78, 0.96) for distinguishing between benign and malignant lesions. In conclusion, the QUS system shows promise in enhancing diagnostic accuracy by leveraging AC, SoS, and ESD. Further studies are needed to validate these findings and optimize the system for clinical use.
Keyphrases
- artificial intelligence
- ultrasound guided
- high resolution
- magnetic resonance imaging
- deep learning
- big data
- machine learning
- end stage renal disease
- newly diagnosed
- fine needle aspiration
- endoscopic submucosal dissection
- prognostic factors
- chronic kidney disease
- peritoneal dialysis
- contrast enhanced ultrasound
- type diabetes
- risk assessment
- convolutional neural network
- metabolic syndrome
- optic nerve
- mass spectrometry
- skeletal muscle
- human health